雌激素阻断剂市场：依产品类型、依应用、依配销通路、按地区

2023年，雌激素阻断剂的全球市场规模为150.2亿美元，预计2023年至2030年复合年增长率为6.5%，到2030年达到233.4亿美元。

图 1. 2023 年按地区分類的雌激素阻断剂全球市场占有率(%)

雌激素阻断剂是 FTM（女变男）患者使用的药物，作为荷尔蒙替代疗法 (HRT) 的一部分，以抑制体内雌激素的影响。它也具有促进男性第二性征发育的作用。雌激素阻断剂有不同类型，有些比其他更有效。

雌激素阻断剂可以以锭剂或註射剂的形式服用。它们通常作为更大的 HRT 治疗计划的一部分开出，并且通常被使用者很好地耐受。在大多数情况下，您无需住院即可服用这些药物，通常可以在家中服用。

市场动态

雌激素阻断剂主要用于治疗与荷尔蒙相关的疾病，例如卵巢症候群（PCOS）、子宫内膜异位症和乳癌。随着这些疾病在国际上流行的增加，对雌激素阻断剂的需求也在增加，从而推动了市场的扩张。

例如，2023年6月28日，世界卫生组织（WHO）发布的报告指出，卵巢症候群（PCOS）是影响育龄妇女的重要公共卫生问题，被认为是最常见的荷尔蒙激素之一。失调。据估计，这种疾病每年影响 8-13% 的育龄妇女，高达 70% 的病例未被确诊。

另一方面，与任何药物一样，雌激素阻断剂也有潜在的风险和副作用。典型的副作用包括潮热、忧郁、关节不适和胆固醇水平升高。在某些情况下，长期使用雌激素阻断剂会增加心血管问题和骨质流失的风险。患者对雌激素阻断剂的依从性和可接受性可能会受到安全性问题和可能的副作用的影响。

本研究的主要特点

• 本报告详细分析了全球雌激素阻断剂市场，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
• 它还阐明了各个细分市场的潜在商机，并解释了该市场有吸引力的投资提案矩阵。
• 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
• 它根据公司亮点、产品系列、主要亮点、财务实绩和策略等参数，介绍了全球雌激素阻断剂市场的主要企业。
• 该报告的见解使行销人员和公司负责人能够就未来的产品发布、升级、市场扩张和行销策略做出明智的资讯。
• 雌激素阻断剂的全球市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 透过用于分析全球雌激素阻断剂市场的各种策略矩阵，将促进相关人员的决策。

目录

第1章研究目的与前提

• 研究目标
• 假设
• 简称

第2章市场展望

• 报告说明
  • 市场定义和范围
• 执行摘要
• Coherent Opportunity Map（COM）

第3章市场动态、法规及趋势分析

• 市场动态
  • 促进因素
• 荷尔蒙相关疾病的盛行率增加
  • 抑制因素
• 副作用和安全问题
  • 机会
• 扩大适应症
• 影响分析
• 主要亮点
• 监管场景
• 产品发布/核准
• PEST分析
• 波特的分析
• 併购场景

第4章全球雌激素阻断剂市场－冠状病毒(COVID-19) 大流行的影响

• 新型冠状病毒感染疾病（COVID-19）的流行病学
• 供需面分析
• 经济影响

第5章全球雌激素阻断剂市场，依产品类型，2018-2030

• 选择性雌激素受体调节剂 (SERM)
• Aromatase酶抑制剂
• 雌激素受体下稳压器(ERD)
• 其他的

第6章全球雌激素阻断剂市场，依应用分类，2018-2030

• 乳癌治疗
• 荷尔蒙替代疗法（HRT）
• 不孕症治疗
• 停经后骨质疏鬆症
• 其他的

第7章全球雌激素阻断剂市场，依配销通路，2018-2030

• 医院药房
• 零售药房
• 线上药房

第8章全球雌激素阻断剂市场，按地区，2018-2030

• 北美洲
• 美国
• 加拿大
• 欧洲
• 德国
• 英国
• 西班牙
• 法国
• 义大利
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 中国
• 印度
• 日本
• 澳洲
• 韩国
• ASEAN
• 其他亚太地区
• 拉丁美洲
• 巴西
• 阿根廷
• 墨西哥
• 其他拉丁美洲
• 中东
• 海湾合作委员会国家
• 以色列
• 其他中东地区
• 非洲
• 南非
• 北非
• 中部非洲

第9章竞争形势

• Pfizer Inc.
• Novartis AG
• AstraZeneca PLC
• Eli Lilly and Company
• Merck & Co., Inc.
• Bristol Myers Squibb Company
• Sanofi SA
• AbbVie Inc.
• GlaxoSmithKline plc
• Olema Pharmaceuticals, Inc.
• Scorpion Therapeutics, Inc.
• Allorion Therapeutics Inc
• Carrick Therapeutics Limited
• Criterium, Inc.
• F.Hoffmann-La Roche

第10章章

• 调查方法
• 关于出版商

The global estrogen blockers market size was valued at US$ 15.02 billion in 2023 and is expected to reach US$ 23.34 billion by 2030, growing at a CAGR of 6.5% from 2023 to 2030.

Figure 1. Global Estrogen Blockers Market Share (%), By Region, 2023

Estrogen blockers are medicines that are used by FTM (female to male) individuals as part of their hormone replacement therapy (HRT) to suppress the effects of estrogen in the body. They can also help to promote the development of male secondary sexual characteristics. There are many different types of estrogen blockers available, and some are more effective than others.

Estrogen blockers can be taken in the form of tablets or injections. They are usually prescribed as part of a larger HRT treatment plan and are generally well tolerated by individuals who take them. For the most part, a hospital stay is not required when taking these medications, and they can often be given at home.

Market Dynamics

Estrogen blockers are largely used to treat hormone-related diseases like polycystic ovary syndrome (PCOS), endometriosis, and breast cancer. The demand for estrogen blockers rises as the prevalence of these illnesses rises internationally, fueling market expansion.

For instance, on June 28, 2023, according to a report published by the World Health Organization, reported that polycystic ovary syndrome (PCOS) is a significant public health problem and considered as one of the commonest hormonal disturbances affecting women of reproductive age. The condition affects an estimated 8-13% of women of reproductive age every year, and up to 70% of cases are undiagnosed.

On the other hand, like any drug, estrogen blockers have potential risks and adverse effects. Hot flashes, mood swings, joint discomfort, and increases in cholesterol levels are examples of typical side effects. In some circumstances, long-term use of estrogen blockers may raise the risk of cardiovascular issues and bone loss. Patients' compliance with and acceptance of estrogen blockers may be impacted by safety worries and possible side effects.

Key features of the study:

• This report provides in-depth analysis of the global estrogen blockers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global estrogen blockers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer Inc., Novartis AG, AstraZeneca PLC, Eli Lilly and Company, Merck & Co., Inc., Bristol Myers Squibb Company, Sanofi S.A., AbbVie Inc., GlaxoSmithKline plc, Olema Pharmaceuticals, Inc., Scorpion Therapeutics, Inc., Allorion Therapeutics Inc, Carrick Therapeutics Limited, Criterium, Inc. and Hoffmann-La Roche
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global estrogen blockers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global estrogen blockers market

Detailed Segmentation:

• Global Estrogen Blockers Market, By Product Type:
  • Selective Estrogen Receptor Modulators (SERMs)
  • Aromatase Inhibitors
  • Estrogen Receptor Downregulators (ERDs)
  • Others
• Global Estrogen Blockers Market, By Application:
  • Breast Cancer Treatment
  • Hormone Replacement Therapy (HRT)
  • Infertility Treatment
  • Post-Menopausal Osteoporosis
  • Others
• Global Estrogen Blockers Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Estrogen Blockers Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Global Estrogen Blockers Market, By Company:
  • Pfizer Inc.
  • Novartis AG
  • AstraZeneca PLC
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Bristol Myers Squibb Company
  • Sanofi S.A.
  • AbbVie Inc.
  • GlaxoSmithKline plc
  • Olema Pharmaceuticals, Inc.
  • Scorpion Therapeutics, Inc.
  • Allorion Therapeutics Inc
  • Carrick Therapeutics Limited
  • Criterium, Inc.
  • F.Hoffmann-La Roche

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Estrogen Blockers, By Product Type
  • Market Estrogen Blockers, By Application
  • Market Estrogen Blockers, By Distribution Channel
  • Market Estrogen Blockers, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing Prevalence of Hormone-related Disorders
  • Restraints
• Side Effects and Safety Concerns
  • Opportunities
• Expansion of Indications
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Estrogen Blockers Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Estrogen Blockers Market , By Product Type, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Selective Estrogen Receptor Modulators (SERMs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Aromatase Inhibitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Estrogen Receptor Downregulators (ERDs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Global Estrogen Blockers Market , By Application, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Breast Cancer Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Hormone Replacement Therapy (HRT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Infertility Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Post-Menopausal Osteoporosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Estrogen Blockers Market , By Distribution Channel, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, 2019 - 2030
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Global Estrogen Blockers Market , By Region, 2018-2030, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2023 and 2030 (%)
  • Y-o-Y Growth Analysis, For Country 2019 -2030
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• U.S.
• Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• Germany
• U.K.
• Spain
• France
• Italy
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
• South Africa
• North Africa
• Central Africa

9. Competitive Landscape

• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
• AstraZeneca PLC
• Eli Lilly and Company
• Merck & Co., Inc.
• Bristol Myers Squibb Company
• Sanofi S.A.
• AbbVie Inc.
• GlaxoSmithKline plc
• Olema Pharmaceuticals, Inc.
• Scorpion Therapeutics, Inc.
• Allorion Therapeutics Inc
• Carrick Therapeutics Limited
• Criterium, Inc.
• F.Hoffmann-La Roche
• Analyst Views

10. Section

• Research Methodology
• About us